| Name | Title | Contact Details |
|---|
Hardric Laboratories Inc is a North Chelmsford, MA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Ambulatory care at Hotel Dieu Hospital (HDH) is specialized care that may include a scheduled visit to one or more hospital clinics, diagnostic or procedural areas. In some cases, a single health care professional, for example a surgeon or internal medicine physician, may see patients in a traditional clinic setting. Increasingly, patients and families will receive care in a team-based inter-disciplinary and/or inter-professional program, such as our pre-surgical screening, diabetes, breast assessment, bariatric, chronic pain or cardiac rehabilitation programs. Ambulatory care at HDH includes care for patients with urgent and less critical emergency problems at our Urgent Care Centre. Hotel Dieu Hospital has a very active ambulatory surgery program where most patients return home the same day. We also have a short-stay facility in the form of a satellite post-anesthetic care unit that supports patients who need extended time for pain control and rehabilitation therapy. This facility is key to our innovative fast-track total hip and knee arthroplasty program. Hotel Dieu Hospital is a faith-based, academic hospital where research and learning take place every day and where we are committed to partnership with patients and families. We actively engage in implementing innovative models of care that support patient care, as well as regional and academic health care needs. Affiliated with Queen`s University, we serve as a major teaching location for learners from across the Faculty of Health Sciences, including medical, nursing and allied health learners. And research at Hotel Dieu Hospital contributes to the growing field of knowledge about health care and ambulatory care in Canada and beyond. Ambulatory care at Hotel Dieu Hospital is part of an integrated, cost-effective system of health care in Southeastern Ontario.
Xanitos is a management company that provides hospital housekeeping, patient transport, and central laundries services. It is differentiated by its patented XRO System for cleaning patient rooms, its outstanding operations management team, and by being a private company whose priority is giving top quality service, believing that by so doing, profits will follow. Graeme Crothall, founder and CEO, has 45 years’ experience in hospital housekeeping and during that time he has founded and led four successful companies in the industry whose revenues today exceed $2.5 billion. In 2008 Graeme founded Xanitos by acquiring two small companies, one of which owned the XRO patient room cleaning system, and continuing his track-record of providing top quality service, attracting and holding excellent operations management, and always growing the companies he leads. Xanitos continues to grow because of its patented XRO System for cleaning patient rooms, its outstanding operations management team, and by being a private company whose priority is giving top quality service.
MicroLight Corporation of America is a Missouri City, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
MCRA is the leading global full-service medical device, diagnostics, and biologics CRO and consulting advisory firm. MCRA delivers to its client`s industry experience, integrating its six business value creators: regulatory, clinical research, reimbursement, healthcare compliance, quality assurance, and distribution logistics to provide a dynamic, market-leading effort from innovation conception to commercialization. MCRA`s integrated application of these key value-creating initiatives provides unparalleled value for its clients. MCRA has offices in Washington, DC, Hartford, CT, New York, NY, and Tokyo, Japan and serves nearly 1,000 clients globally. Its core focus areas of therapeutic experience include orthopedics, spine, biologics, cardiovascular, diagnostic imaging, wound care, artificial intelligence, dental, anesthesia, general surgery, digital health, neurology, robotics, oncology, general and plastic surgery, urology, and in vitro diagnostic (IVD) devices and medical device cybersecurity. MCRA places particular emphasis on its expertise working with companies in all stages of development and throughout the technology life cycle by ushering technologies from the conceptual pre-clinical stage to market approval.